ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NTT DATA Collaborates with Leading Academic Medical System on New Model of In-Home Care

  • Model incorporates GenAI agent, care pathway automation and analytics
  • Comprehensive approach supports high-quality outcomes for home care
  • Interactive solution transforms patient and provider experience

NTT DATA, a global leader in healthcare IT, and Duke Health, a world-class academic and healthcare system, are collaborating to create a highly interactive and technologically advanced model for augmented home care delivery.

This new home-care model will integrate multiple technologies, including a GenAI-driven virtual agent from Ellipsis Health, automation, device interoperability, remote patient monitoring and a patient app and portal. The solution will keep medical staff in direct contact with the patient to ensure a human is always in the loop while allowing patients to receive more of their care at home.

To begin development of this new care delivery model, all parties will work together to develop a clinical trial to test the patient experience and usability of an AI virtual agent in conducting teaching and technical support for remote patient monitoring devices.

“This groundbreaking approach revolutionizes healthcare by turning the patient's home into a human-centered and high-value care setting," said John Frownfelter, MD, FACP, Lead for Data-Driven Health, NTT DATA. “Today’s models for care at home continue to limp along with insufficient resources and piecemeal technologies. We are taking today’s best practices to the next level with the power of automation and generative AI.”

“Ellipsis Health is proud to support this innovative approach to transforming home care delivery for patients,” said Mainul Mondal, Founder and CEO, Ellipsis Health. “By integrating our AI virtual agent with NTT DATA’s solution, we enhance patient access to holistic, personalized care, empowering families and caregivers with vital data and insights while reducing the burden on healthcare professionals. This initiative offers significant support for our loved ones during their healthcare journeys, ensuring that compassionate, efficient, and comprehensive care is accessible to everyone, right in the comfort of home.”

“This partnership is focused on using advanced digital technology to address a broad range of patient needs efficiently and cost-effectively,” said Emily Norboge, Chief Research Informatics Officer, The Duke Cancer Institute. “This approach for in-home care advances our mission to deliver the best medical outcomes with positive experiences for our patients and staff.”

To read more about NTT DATA’s healthcare and life sciences visit: https://us.nttdata.com/en/industries/healthcare-and-life-sciences/healthcare-providers

About NTT DATA

NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. We invest over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure, and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group and headquartered in Tokyo. Visit us at nttdata.com

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.